A Study of SHR0410 in Hemodialysis Patients With Pruritus

A Study of SK-1405 in Hemodialysis Patients With Uremic Pruritus

NCT03218501 ·Status: COMPLETED ·Phase: PHASE2

A Multi-site Bridging Study of Nalfurafine Hydrochloride Orally Disintegrating Tablet

NCT04728984 ·Status: UNKNOWN ·Phase: PHASE3

Safety and Tolerance of Increased Doses of HRS-1780 Tablets in Healthy Subjects

NCT05638126 ·Status: UNKNOWN ·Phase: PHASE1

CR845-310302: A Study to Evaluate the Safety and Efficacy of Difelikefalin in Advanced Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus

NCT05356403 ·Status: TERMINATED ·Phase: PHASE3

A Study of HSK21542 in a Peritoneal Dialysis Pruritus Population.

NCT06290375 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Phase 3 Study of QLG2198 in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus

NCT06446310 ·Status: RECRUITING ·Phase: PHASE3

A Randomized-Withdrawal Phase 3 Study Evaluating the Safety and Efficacy of Oral Nalfurafine HCl (AC-820)in Subjects on Hemodialysis With Uremic Pruritus (Renal Itch)

NCT00793156 ·Status: UNKNOWN ·Phase: PHASE3

A Study to Evaluate the Safety and Efficacy of Difelikefalin in Advanced Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus

NCT05342623 ·Status: TERMINATED ·Phase: PHASE3

Pharmacokinetic/Pharmacokinetic and Safety Studies of SHR4640 in Subjects With Moderate Renal Insufficiency and Healthy Subjects

NCT05954169 ·Status: COMPLETED ·Phase: PHASE1

Study of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus

NCT02143648 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Efficacy and Safety of Nalfurafine Hydrochloride ODT for Moderate-to-Severe Pruritus in Patients on Peritoneal Dialysis

NCT07098351 ·Status: RECRUITING ·Phase: NA

Safety and Pharmacokinetics of HRS-1780 in Healthy Subjects and Subjects With Impaired Renal Function

NCT06039254 ·Status: UNKNOWN ·Phase: PHASE1

Phase 3 Study of Difelikefalin in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus

NCT05885737 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus

NCT03617536 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety Study of TRK-820 to Treat Conventional-treatment-resistant Pruritus in Patients Receiving Hemodialysis

NCT01513161 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of SHR-2010 Injection in the Treatment of Primary IgA Nephropathy

NCT05847920 ·Status: TERMINATED ·Phase: PHASE2

A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of HSK21542 Injection in Subjects Undergoing Hemodialysis

NCT04470154 ·Status: COMPLETED ·Phase: PHASE2

Safety and Tolerance of Increased Doses of SHR-2106 Injection in Healthy Subjects

NCT05948059 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1

Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus

NCT06593392 ·Status: RECRUITING ·Phase: PHASE2

Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis

NCT01660243 ·Status: TERMINATED ·Phase: PHASE2

Evaluate the Efficacy and Safety of SHR1459 Tablets in Patients With Primary Membranous Nephropathy

NCT05136456 ·Status: UNKNOWN ·Phase: PHASE2

Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus

NCT02858726 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KN060 in ESRD Dialysis Patients

NCT07201467 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Efficacy, Local Tolerance and Patient Acceptability of a Moisturizing Emollient in Patients With Uremic Xerosis

NCT01084720 ·Status: COMPLETED ·Phase: PHASE3

Phase II Randomized, Open-label, Multicenter Clinical Study Evaluating the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of SHR-2173 Injection in Patients With Primary Membranous Nephropathy

NCT07289763 ·Status: RECRUITING ·Phase: PHASE2